Site icon Market Globalist

Why RedHill Biopharma (RDHL) Stock Is Falling 11% Today?

SIG Stock

SIG Stock

The biopharmaceuticals firm RedHill Biopharma Ltd. (RDHL) is facing a -11.27% decline in its share price during pre-market trading today following the announcement of an offering of $10 million of its American Depositary Shares (ADS).

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.  

What happened?


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


RedHill Biopharma is involved in the biopharmaceuticals segment focused mostly on infectious diseases and gastrointestinal disorders.

In addition to the gastrointestinal drugs Movantik and Talicia, Redhill offers Aemcolo for the treatment of travelers’ diarrhea in adults.

Among RedHill’s clinical late-stage development programs are:

On Monday, RedHill Biopharma announced that it has signed an underwriting agreement with H.C. Wainwright & Co., LLC.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Exit mobile version